Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05720507 · ClinicalTrials.gov registry record · NA

Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty

A NA study of Aging, sponsored by University of Montana.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT05720507: Recruiting NA study of Aging, sponsored by University of Montana.

NCT05720507 is a NA study of Aging that is actively recruiting participants, run by University of Montana. The registered enrollment target is 36 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05720507, a NA study of Aging, is actively recruiting participants, sponsored by University of Montana.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This project explores a novel means of health promotion and prevention of age-related physical frailty, which is designed to overcome barriers to access and promote autonomy in managing physical health.

Primary Outcome

Self-reported measure of engagement with preventive care or wellness activities

Conditions Studied

Interventions

  • BEHAVIORAL Cafe Move

Study Locations (1)

Montana

  • University of Montana - Missoula

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-04-29
Est. Completion 2027-02-28
Phase NA
University of Montana

24 total trials

What NCT05720507 shows while recruiting

NCT05720507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Cafe Move is the first listed.

NCT05720507 reports a single indexed study location in Montana.

Frequently Asked Questions

What is clinical trial NCT05720507 about?

NCT05720507 is a clinical study titled "Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty". This project explores a novel means of health promotion and prevention of age-related physical frailty, which is designed to overcome barriers to access and promote autonomy in managing physical health.

What is the current status of trial NCT05720507?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-04-29. Estimated completion is 2027-02-28.

What conditions does trial NCT05720507 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT05720507?

The interventions under investigation include: Cafe Move (BEHAVIORAL).

Who is sponsoring clinical trial NCT05720507?

This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05720507 being conducted?

This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05720507's enrollment target sits among peer trials

36 181st of 262 higher than 81 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05720507, the US trial registry maintained by the National Library of Medicine. NCT05720507 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.